SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-09-057916
Filing Date
2009-10-06
Accepted
2009-10-06 12:47:49
Documents
1
Period of Report
2009-10-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6244
  Complete submission text file 0001104659-09-057916.txt   8187
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O CURAGEN CORP 555LONG WHARF DR. 11TH FL. NEW HAVEN CT 06511
Business Address
SHANNON TIMOTHY M (Reporting) CIK: 0001207114 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 091107547